Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L True

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Genetics|November 18, 2009
The spontaneous appearance rate of the yeast prion [PSI+] and its implications for the evolution of the evolvability properties of the [PSI+] systemAlex K Lancaster, J Patrick Bardill, Heather L True, et al.
Prion|September 23, 2009
Requirements of Hsp104p activity and Sis1p binding for propagation of the [RNQ(+)] prionJ Patrick Bardill, Jennifer E Dulle, Jonathan R Fisher, et al.
The Journal of Cell Biology|October 23, 2013
Soluble oligomers are sufficient for transmission of a yeast prion but do not confer phenotypeJennifer E Dulle, Rachel E Bouttenot, Lisa A Underwood, et al.
Biochemistry|October 28, 1997
Site-specific phosphorylation of the human immunodeficiency virus type-1 Rev protein accelerates formation of an efficient RNA-binding conformationD E Fouts, H L True, K A Cengel, et al.
The Journal of Family Practice|September 1, 1986
Effect of a rapid diagnostic method on prescribing patterns and ordering of throat cultures for streptococcal pharyngitisB L True, B L Carter, C E Driscoll, et al.
Molecular and Cellular Biology|June 6, 2007
Prion protein repeat expansion results in increased aggregation and reveals phenotypic variabilityElizabeth M H Tank, David A Harris, Amar A Desai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2009
Linezolid in the treatment of multidrug-resistant tuberculosisG F Schecter, C Scott, L True, et al.
Pharmacotherapy|November 28, 2006
Pharmacokinetic bioequivalence of enfuvirtide using a needle-free device versus standard needle administrationAndrea L True, Yu-Yuan Chiu, Ralph A Demasi, et al.
Human Molecular Genetics|September 13, 2015
Myofibrillar disruption and RNA-binding protein aggregation in a mouse model of limb-girdle muscular dystrophy 1DRocio Bengoechea, Sara K Pittman, Elizabeth P Tuck, et al.
The Journal of Biological Chemistry|June 13, 2014
Myopathy-causing mutations in an HSP40 chaperone disrupt processing of specific client conformersKevin C Stein, Rocio Bengoechea, Matthew B Harms, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Genetics|November 18, 2009
The spontaneous appearance rate of the yeast prion [PSI+] and its implications for the evolution of the evolvability properties of the [PSI+] systemAlex K Lancaster, J Patrick Bardill, Heather L True, et al.
Prion|September 23, 2009
Requirements of Hsp104p activity and Sis1p binding for propagation of the [RNQ(+)] prionJ Patrick Bardill, Jennifer E Dulle, Jonathan R Fisher, et al.
The Journal of Cell Biology|October 23, 2013
Soluble oligomers are sufficient for transmission of a yeast prion but do not confer phenotypeJennifer E Dulle, Rachel E Bouttenot, Lisa A Underwood, et al.
Biochemistry|October 28, 1997
Site-specific phosphorylation of the human immunodeficiency virus type-1 Rev protein accelerates formation of an efficient RNA-binding conformationD E Fouts, H L True, K A Cengel, et al.
The Journal of Family Practice|September 1, 1986
Effect of a rapid diagnostic method on prescribing patterns and ordering of throat cultures for streptococcal pharyngitisB L True, B L Carter, C E Driscoll, et al.
Molecular and Cellular Biology|June 6, 2007
Prion protein repeat expansion results in increased aggregation and reveals phenotypic variabilityElizabeth M H Tank, David A Harris, Amar A Desai, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2009
Linezolid in the treatment of multidrug-resistant tuberculosisG F Schecter, C Scott, L True, et al.
Pharmacotherapy|November 28, 2006
Pharmacokinetic bioequivalence of enfuvirtide using a needle-free device versus standard needle administrationAndrea L True, Yu-Yuan Chiu, Ralph A Demasi, et al.
Human Molecular Genetics|September 13, 2015
Myofibrillar disruption and RNA-binding protein aggregation in a mouse model of limb-girdle muscular dystrophy 1DRocio Bengoechea, Sara K Pittman, Elizabeth P Tuck, et al.
The Journal of Biological Chemistry|June 13, 2014
Myopathy-causing mutations in an HSP40 chaperone disrupt processing of specific client conformersKevin C Stein, Rocio Bengoechea, Matthew B Harms, et al.
Pageof 10